Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;41(10):1366-1375.
doi: 10.1016/j.healun.2022.07.018. Epub 2022 Jul 25.

The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease

Eileen Hsich  1 , Tajinder P Singh  1 , Wida S Cherikh  1 , Michael O Harhay  1 , Don Hayes Jr  1 , Michael Perch  1 , Luciano Potena  1 , Aparna Sadavarte  1 , Kelsi Lindblad  1 , Andreas Zuckermann  1 , Josef Stehlik  2 ; International Society for Heart and Lung Transplantation  1
Affiliations

The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease

Eileen Hsich et al. J Heart Lung Transplant. 2022 Oct.
No abstract available

Keywords: Heart Transplant; restrictive cardiomyopathy and outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagnosis distribution by age group (transplants: January 1992-June 2018).
Figure 2
Figure 2
Diagnosis distribution by era (transplants: January 1992-June 2018).
Figure 3
Figure 3
Diagnosis distribution by geographic region (transplants: January 1992-June 2018).
Figure 4
Figure 4
Percent of recipients who experienced rejection between discharge and 1 year follow-up by era (transplant follow-ups: January 2005-June 2018).
Figure 5
Figure 5
Freedom from cardiac allograft vasculopathy (CAV) by diagnosis (transplants: January 1992-June 2017).
Figure 6
Figure 6
Kaplan-Meier survival within 12 months by diagnosis (transplants: January 1992-June 2017).
Figure 7
Figure 7
Relative incidence of leading causes of death (transplant deaths: January 2010-June 2018).
Figure 8
Figure 8
Kaplan-Meier survival within 12 months by (A) era and (B) geographic region (transplants: January 1992-June 2017).
Figure 9
Figure 9
Kaplan-Meier survival within 12 months by recipient (A) sex and (B) age (years) (transplants: January 1992-June 2017).
Figure 10
Figure 10
Kaplan-Meier survival within 12 months by recipient GFR (transplants: January 1994-June 2017). GFR was estimated using the Cockcroft-Gault formula.
Figure 11
Figure 11
Kaplan-Meier survival within 5 years conditional on survival to 1 year by diagnosis (transplants: January 1992-June 2013).
Figure 12
Figure 12
Kaplan-Meier survival within 5 years conditional on survival to 1 year by severe renal dysfunction within 1 year (transplants: January 1992-June 2013). Severe renal dysfunction was calculated as creatinine >2.5 mg/dl, dialysis, or renal transplant.
Figure 13
Figure 13
Statistically significant categorical risk factors for 1 year mortality with 95% confidence limits (transplants January 1992-June 2017).
Figure 14
Figure 14
Multivariable hazard ratio plot for 1 year mortality with 95% confidence limits, by (A) bilirubin, (B) GFR, and (C) PVR (transplants: January 1992-June 2017; n = 4292).
Figure 15
Figure 15
Statistically significant risk factors for 1 year mortality with 95% confidence limits, by (A) donor age (years), and (B) center volume in the previous 3 years (transplants: January 1992-June 2017; n = 4292).
Figure 16
Figure 16
Statistically significant categorical risk factors for 5 year mortality conditional on survival to 1 year with 95% confidence limits (transplants January 1992-June 2013; n = 2490).
See this image and copyright information in PMC

References

    1. Seferovic PM, Polovina M, Bauersachs J, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019;21:553–76. - PubMed
    1. Arbustini E, Narula N, Dec GW, et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol 2013;62:2046–72. - PubMed
    1. Khush KK, Cherikh WS, Chambers DC, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019;38:1056–66. - PMC - PubMed
    1. Khush KK, Hsich E, Potena L, et al. International Society for H and Lung T. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult heart transplantation report-2021; focus on recipient characteristics. J Heart Lung Transplant 2021;40:1035–49. - PMC - PubMed
    1. Khush KK, Potena L, Cherikh WS, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics. J Heart Lung Transplant 2020;39:1003–15. - PMC - PubMed